Rajeev M. Dhere

Pune, MH, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Safety and Preliminary Efficacy of Dengue Monoclonal Antibody in Adult Patients: A Randomized Clinical Trial.

Safety and Preliminary Efficacy of Dengue Monoclonal Antibody in Adult Patients: A Randomized Clinical Trial.

Journal: JAMA network open
Published: August 25, 2026

Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine.

Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine.

Journal: Human vaccines & immunotherapeutics
Published: March 18, 2026

Immunogenicity and safety of a dose-sparing inactivated poliovirus vaccine in infants in India: a phase 2/3, double-blind, randomised controlled trial.

Immunogenicity and safety of a dose-sparing inactivated poliovirus vaccine in infants in India: a phase 2/3, double-blind, randomised controlled trial.

Journal: The Lancet. Infectious diseases
Published: December 13, 2025

Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples.

Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples.

Journal: Vaccine
Published: October 25, 2025

Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.

Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.

Journal: Vaccine
Published: October 09, 2025

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond.

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond.

Journal: Human vaccines & immunotherapeutics
Published: September 18, 2025

Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

Journal: Vaccine
Published: July 28, 2025

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 08, 2025

Development of multiplexed flow based assay for simultaneous identification and estimation of meningococcal capsular polysaccharide serogroups A, C, W, Y and X for conjugate vaccine manufacturing.

Development of multiplexed flow based assay for simultaneous identification and estimation of meningococcal capsular polysaccharide serogroups A, C, W, Y and X for conjugate vaccine manufacturing.

Journal: Journal of immunological methods
Published: March 07, 2025

Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.

Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.

Journal: The Lancet. Infectious diseases
Published: January 16, 2025

Evaluation of GC-MS for identification and characterization of pneumococcal serotype 24A, 24B, and 24F capsular polysaccharide.

Evaluation of GC-MS for identification and characterization of pneumococcal serotype 24A, 24B, and 24F capsular polysaccharide.

Journal: Biochemical and biophysical research communications
Published: June 20, 2024

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.

Journal: The Lancet. Infectious diseases
Published: June 05, 2024
Showing 1-12 of 63

Last Updated: 09/26/2026